Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9050 | 1125 | 56.0 | 85% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
520 | 14322 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BRAIN TARGETING | Author keyword | 34 | 37% | 6% | 73 |
2 | SMART DRUG DELIVERY | Address | 28 | 29% | 7% | 83 |
3 | ANGIOPEP 2 | Author keyword | 27 | 92% | 1% | 11 |
4 | BRAIN DELIVERY | Author keyword | 12 | 31% | 3% | 33 |
5 | ANGIOPEP | Author keyword | 12 | 86% | 1% | 6 |
6 | OX26 | Author keyword | 12 | 86% | 1% | 6 |
7 | BRAIN TARGETED DELIVERY | Author keyword | 9 | 64% | 1% | 9 |
8 | BRAIN DRUG TARGETING | Author keyword | 8 | 75% | 1% | 6 |
9 | TE FAR TI GRP | Address | 6 | 80% | 0% | 4 |
10 | ABSORPTIVE MEDIATED ENDOCYTOSIS | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BRAIN TARGETING | 34 | 37% | 6% | 73 | Search BRAIN+TARGETING | Search BRAIN+TARGETING |
2 | ANGIOPEP 2 | 27 | 92% | 1% | 11 | Search ANGIOPEP+2 | Search ANGIOPEP+2 |
3 | BRAIN DELIVERY | 12 | 31% | 3% | 33 | Search BRAIN+DELIVERY | Search BRAIN+DELIVERY |
4 | ANGIOPEP | 12 | 86% | 1% | 6 | Search ANGIOPEP | Search ANGIOPEP |
5 | OX26 | 12 | 86% | 1% | 6 | Search OX26 | Search OX26 |
6 | BRAIN TARGETED DELIVERY | 9 | 64% | 1% | 9 | Search BRAIN+TARGETED+DELIVERY | Search BRAIN+TARGETED+DELIVERY |
7 | BRAIN DRUG TARGETING | 8 | 75% | 1% | 6 | Search BRAIN+DRUG+TARGETING | Search BRAIN+DRUG+TARGETING |
8 | ABSORPTIVE MEDIATED ENDOCYTOSIS | 6 | 100% | 0% | 4 | Search ABSORPTIVE+MEDIATED+ENDOCYTOSIS | Search ABSORPTIVE+MEDIATED+ENDOCYTOSIS |
9 | GLIOMA PENETRATION | 6 | 100% | 0% | 4 | Search GLIOMA+PENETRATION | Search GLIOMA+PENETRATION |
10 | POLYSORBATE 80 | 6 | 18% | 2% | 27 | Search POLYSORBATE+80 | Search POLYSORBATE+80 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 80 COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES | 95 | 70% | 7% | 80 |
2 | POLYBUTYL CYANOACRYLATE NANOPARTICLES | 41 | 56% | 4% | 50 |
3 | BARRIER IN VIVO | 38 | 89% | 2% | 17 |
4 | DELIVERY VECTOR ANGIOPEP 2 | 30 | 84% | 1% | 16 |
5 | ANTITRANSFERRIN RECEPTOR ANTIBODY | 29 | 58% | 3% | 33 |
6 | PEG PLGA NANOPARTICLES | 25 | 77% | 2% | 17 |
7 | TAT MODIFIED CHOLESTEROL | 21 | 90% | 1% | 9 |
8 | CONJUGATED PEGYLATED NANOPARTICLES | 19 | 80% | 1% | 12 |
9 | DALARGIN | 19 | 64% | 2% | 18 |
10 | HUMAN INSULIN RECEPTOR | 17 | 24% | 6% | 62 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? | 2014 | 32 | 127 | 69% |
Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody | 2015 | 4 | 79 | 53% |
Transport of drugs across the blood-brain barrier by nanoparticles | 2012 | 101 | 99 | 67% |
Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases | 2010 | 171 | 63 | 38% |
Drug transport across the blood-brain barrier | 2012 | 105 | 97 | 34% |
Nanoparticulate systems for brain delivery of drugs | 2001 | 539 | 39 | 49% |
Nanoscale drug delivery systems and the blood-brain barrier | 2014 | 19 | 145 | 32% |
REENGINEERING BIOPHARMACEUTICALS FOR TARGETED DELIVERY ACROSS THE BLOOD-BRAIN BARRIER | 2012 | 44 | 59 | 61% |
Nanoparticles and Blood-Brain Barrier: The Key to Central Nervous System Diseases | 2014 | 15 | 165 | 36% |
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier | 2015 | 1 | 114 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SMART DRUG DELIVERY | 28 | 29% | 7.4% | 83 |
2 | TE FAR TI GRP | 6 | 80% | 0.4% | 4 |
3 | TARGETED BIOTHER Y | 3 | 43% | 0.5% | 6 |
4 | STAB VIDA | 3 | 100% | 0.3% | 3 |
5 | BIOTECHNOL BTI | 2 | 67% | 0.2% | 2 |
6 | RADIO ELED MOL | 2 | 50% | 0.3% | 3 |
7 | MINIST EDUC PLA | 2 | 29% | 0.4% | 5 |
8 | NEURODEGENERAT S | 2 | 33% | 0.4% | 4 |
9 | AA UKHTOMSKY PHYSIOL | 1 | 50% | 0.2% | 2 |
10 | EA 2648 | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000135604 | BBB//TRANSENDOTHELIAL ELECTRICAL RESISTANCE//PHYSIOPATHOL BARRIERE HEMATO ENCEPHAL |
2 | 0.0000132616 | NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE |
3 | 0.0000125487 | CONVECTION ENHANCED DELIVERY//GLIADEL//CARMUSTINE WAFERS |
4 | 0.0000114422 | L DOPA PRODRUGS//6 HYDROXYDOPAMINE 6 OHDA LESIONED RAT//PROXIMAGEN NEUROSCI PLC |
5 | 0.0000110927 | CANCER NANOTECHNOLOGY//NANOSCI NANOENGN INITIAT NUSNNI//CHEMOTHERAPEUTIC ENGINEERING |
6 | 0.0000110134 | LIPID NANOCAPSULES//U1066//U646 |
7 | 0.0000095098 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//SOLID LIPID NANOPARTICLE |
8 | 0.0000089967 | BOVINE SERUM ALBUMIN NANOPARTICLES//HUMAN SERUM ALBUMIN NANOPARTICLES//COACERVATION METHOD |
9 | 0.0000080298 | GEORGE M LEADER FAMILY ALZHEIMERS DIS//CONDENSED MAT NANOSCI//FERRITIN RECEPTORS |
10 | 0.0000076286 | INTRACAROTID CHEMOTHERAPY//RMP 7//INTRACAROTID INFUSION |